PT  - JOURNAL ARTICLE
AU  - A. Viehweger
AU  - F. Kühnl
AU  - C. Brandt
AU  - B. König
AU  - A. C. Rodloff
TI  - Increased PCR screening capacity using a multi-replicate pooling scheme
AID  - 10.1101/2020.04.16.20067603
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.16.20067603
4099  - http://medrxiv.org/content/early/2020/07/10/2020.04.16.20067603.short
4100  - http://medrxiv.org/content/early/2020/07/10/2020.04.16.20067603.full
AB  - Effective public health response to viral outbreaks such as SARS-CoV-2 require reliable information about the spread of the infecting agent. Often real-time PCR screening of large populations is a feasible method to generate this information. Since test capacities are usually limited, pooling of test specimens is often necessary to increase screening capacity, provided that the test sensitivity is not significantly compromised. However, when a traditional pool is tested positive, all samples in the pool need individual retesting, which becomes ineffective at a higher proportion of positive samples. Here, we report a new pooling protocol that mitigates this problem by replicating samples across multiple pools. The resulting pool set allows the sample status to be resolved more often than with traditional pooling. At 2% prevalence and 20 samples per pool, our protocol increases screening capacity by factors of 5 and 2 compared to individual testing and traditional pooling, respectively. The corresponding software to layout and resolve samples is freely available under a BSD license (https://github.com/phiweger/clonepool).Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe corresponding software to layout and resolve samples is freely available under a BSD license (https://github.com/phiweger/clonepool). https://github.com/phiweger/clonepool